Pain Syndrome
Conditions
Keywords
Spinal pain
Brief summary
Randomized, singled blinded, controlled trial of the efficacy of a SCENAR session in patients with vertebral pain. SCENAR is an electrotherapy device.
Interventions
DEVICESCENAR application
Active SCENAR application on the painful area
DEVICESCENAR application with the device off
Placebo SCENAR application on the painful area
Sponsors
Hopital Foch
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Male or female over 18 and under 80 years of age * Suffering of common spinal pain: cervical pain including cervico-brachial neuralgia, lumbar pain including lumbo-radiculalgia * Having attended a pain consultation or referred to a pain consultant during hospitalization * Having signed the consent form * Can be contacted directly by phone if patient is not hospitalized * Be affiliated to a national insurance scheme or benefiting from such a program Non-inclusion Criteria: * Pregnant or breast-feeding women * Patients with a pacemaker * Patients whose skin condition makes the use of SCENAR impossible (wounds, recent scars, skin infections) * Patient whose spinal pain is known to be related to inflammatory pathology (spondylarthropathy, rheumatoid arthritis, chondrocalcinosis), trauma (fractures and dislocations), tumor (metastases, myeloma localization), spondylodiscitis infectious, neurological (intrarachidian tumor or posterior fossa) or radiculalgia with deficient signs * Patients who have already had a SCENAR session * Patients who have already participated in this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Efficacy on resting pain at the end of SCENAR application: NRS | 30 minutes | Self-assessment of pain using the pain numeric rating scale (NRS), on which patients rate their current pain intensity from 0 (no pain) to 10 (worst possible pain) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Efficacy on anxiety the end of SCENAR application: NRS | 30 minutes | Self-assessment of anxiety using the pain numeric rating scale (NRS), on which patients rate their current anxiety from 0 (no anxiety) to 10 (worst possible anxiety) |
| Efficacy on the sensation of spinal blockage at the end of SCENAR application: NRS | 30 minutes | Self-assessment of the sensation of spinal blockage using the numeric rating scale (NRS), on which patients rate their current blockage from 0 (complete blockage) to 10 (perfect mobility) |
| Efficacy on resting pain on the following day: NRS | 1 day | Self-assessment of pain using the pain numeric rating scale (NRS), on which patients rate their current pain intensity from 0 (no pain) to 10 (worst possible pain) |
| Efficacy on pain at mobilization the end of SCENAR application: NRS | 30 minutes | Self-assessment of pain intensity using the pain numeric rating scale (NRS), on which patients rate their current pain intensity from 0 (no pain) to 10 (worst possible pain) |
| Efficacy on the sensation of spinal blockage on the following day: NRS | 1 day | Self-assessment of the sensation of spinal blockage using the numeric rating scale (NRS), on which patients rate their current anxiety from 0 (complete blockage) to 10 (perfect mobility) |
| Efficacy on anxiety on the following day: NRS | 1 day | Self-assessment of anxiety using the numeric rating scale (NRS), on which patients rate their current anxiety from 0 (no anxiety) to 10 (worst possible anxiety) |
| Collection of possible side effects | 1 day | Open question |
| Efficacy on pain at mobilization on the following day: NRS | 1 day | Self-assessment of pain using the pain numeric rating scale (NRS), on which patients rate their current pain intensity from 0 (no pain) to 10 (worst possible pain) |
Countries
France
Outcome results
None listed